Mode
Text Size
Log in / Sign up
N/A N=14 Treatment

Validation of Novel BTE and SP Hearing Aid Models

Hearing Loss

Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Number of Participants With 'Total Impression' Sound Quality as 'Good' — 7; 6; 0; 1 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
BTE hearing aid (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Sonova AG
Primary completion
Jul 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With 'Total Impression' Sound Quality as 'Good'
7; 6; 0; 1
SECONDARY
Number and Percentage of Participants Reporting No Reboots
6; 6; 1; 1
SECONDARY
Number of Participants Reporting Perceived Differences With Both of the App Boost Controls
7; 0
SECONDARY
Number of Participants Reporting Perceived Differences With Both of the App Slider Controls
6; 1

Summary

Participants will wear one set of 2 different BTE hearing aid models based on the gain required by their hearing loss. The hearing aids will be programmed based on a prescriptive approach and participants will be sent out for either one home trial with the less powerful BTEs or for two home trials with the SP (super power) BTEs.

Eligibility Criteria

Inclusion Criteria

  • hearing aid candidacy (N2-N7 hearing loss)
  • healthy outer and middle ears
  • ability to complete questionnaires
  • willingness to use smartphone
  • informed consent documented by a signature
  • willingness to wear a binaural BTE fitting
  • willingness to use app and accessories
  • willingness to adhere to COVID protocols

Exclusion Criteria

  • contraindications to the MD in this study: known hypersensitivity or allergy to investigational product/earmold
  • limited mobility/not able to attend appointments
  • limited ability to describe listening impressions/experiences
  • inability to produce a reliable hearing test result
  • limited dexterity - to point that participant cannot manage hearing aid insertion/removal
  • known psychological disorders
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04882787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search